Are physician-derived joint counts obsolete?

Journal of Rheumatology

Volumn 37, Issue 5, 2010, Pages 883-884

  Keystone, Edward C ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b Rebecca MacDonald Centre for Arthritis and Autoimmune Disease   (Canada)

^c Division of Advanced Therapeutics in Arthritis   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ETANERCEPT;

CLINICAL ASSESSMENT; CLINICAL TRIAL; DISABILITY; DISEASE ACTIVITY; DISEASE COURSE; ECHOGRAPHY; EDITORIAL; FIBROMYALGIA; HEALTH CARE PERSONNEL; HUMAN; IMMUNOGENICITY; JOINT DESTRUCTION; JOINT RADIOGRAPHY; JOINT SWELLING; METACARPOPHALANGEAL JOINT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT; REMISSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SELF EVALUATION; SWOLLEN JOINT COUNT; SYNOVITIS; TENDER JOINT COUNT; TREATMENT OUTCOME; WRIST;

HUMANS; JOINTS; SEVERITY OF ILLNESS INDEX; SYNOVITIS;

EID: 77951818524     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.100242     Document Type: Editorial

References (11)

1. Pham T, Gossec L, Fautrel B, Combe B, Flipo R-M, Goupille P, et al. Physical examination and laboratory tests in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint Bone Spine 2005;72:222-228 (Pubitemid 40591762)
2. Van der Heijde DM, van't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis; first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-920
3. Pincus T, Segurado OG. Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count. Ann Rheum Dis 2006;65:820-822 (Pubitemid 43799185)
4. Pincus T. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care? Bull NYU Hosp Jt Dis 2009;67:254-266
5. Kavanaugh A, Lee SJ, Weng HH, Chon Y, Huang X-Y, Lin S-L. Patient-derived joint counts are a potential alternative for determining Disease Activity Score. J Rheumatol 2010;37:1035-1041
6. Dore RK, Mathews S, Schechtman J, Surbeck W, Mandel D, Patel A, et al. The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis. Clin Exp Rheumatol 2007;25:40-46 (Pubitemid 46477484)
7. Emery P, Genovese MC, van Vollenhoven R, Sharp JT, Patra K, Sasso EH. Less radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis. J Rheumatol 2009:36;1429-1441
8. Drossaers-Bakker KW, Zwinderman AH, Vliet Vlieland TP, Van Zeben D, Vos K, Breedveld FC, et al. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. Arthritis Rheum 2002;47:383-390 (Pubitemid 34856126)
9. Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression.Arthritis Rheum 2006;54:3761-3773
10. Jamal S, Donka T, Kitamura C, Keystone C, Bykerk V, Keystone E. Patient derived outcomes alone are not sufficient of disease activity: the need for joint examination. American College of Rheumatology Annual Scientific Meeting 2006; poster 563.
11. Vastesaeger N, Eu S, Aletaha D, St. Clair EW, Smolen JS. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. Rheumatology 2009;48;1114-1121